journal article·2024-06Open access

Impact of formulation on solid oxygen‐entrapping materials to overcome tumor hypoxia

Megan K. McGovern, Emily Witt, Ashley C. Rhodes, Jinhee Kim, Vivian R. Feig, Jianling Bi, Arielle B. Cafi, Sam Hatfield, Ikenna Nwosu, James D. Byrne

Abstract

Abstract Tumor hypoxia, resulting from rapid tumor growth and aberrant vascular proliferation, exacerbates tumor aggressiveness and resistance to treatments like radiation and chemotherapy. To increase tumor oxygenation, we developed solid oxygen gas‐entrapping materials (O2‐GeMs), which were modeled after clinical brachytherapy implants, for direct tumor implantation. The objective of this study was to investigate the impact different formulations of solid O2‐GeMs have on the entrapment and delivery of oxygen. Using a Parr reactor, we fabricated solid O2‐GeMs using carbohydrate‐based formulations used in the confectionary industry. In evaluating solid O2‐GeMs manufactured from different sugars, the sucrose‐containing formulation exhibited the highest oxygen concentration at 1 mg/g, as well as the fastest dissolution rate. The addition of a surface coating to the solid O2‐GeMs, especially polycaprolactone, effectively prolonged the dissolution of the solid O2‐GeMs. In vivo evaluation confirmed robust insertion and positioning of O2‐GeMs in a malignant peripheral nerve sheath tumor, highlighting potential clinical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Glioma Diagnosis and Treatment · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiation Oncology University of Iowa Iowa City Iowa USA

Department of Biomedical Engineering University of Iowa Iowa City Iowa USA

Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada

Division of Gastroenterology Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA

Department of Mechanical Engineering Massachusetts Institute of Technology Cambridge Massachusetts USA

David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Cambridge Massachusetts USA

Carver College of Medicine University of Iowa Iowa City Iowa USA

Funding

National Institutes of Health · Prostate Cancer Foundation · U.S. Department of Defense · V Foundation for Cancer Research · Dr. Ralph and Marian Falk Medical Research Trust

References (31)

Show source-provided references
1. 10.1186/1471-2407-13-33110.1186/1471-2407-13-331 ↗
2. 10.1038/s41389-017-0011-910.1038/s41389-017-0011-9 ↗
3. 10.2147/HP.S9341310.2147/HP.S93413 ↗
4. 10.1016/j.clon.2021.08.01410.1016/j.clon.2021.08.014 ↗
5. 10.1002/advs.20220599510.1002/advs.202205995 ↗
6. KleinerPKRF KuchmanMJ.USA.1980.
7. 10.1371/journal.pone.017806410.1371/journal.pone.0178064 ↗
8. 10.1038/s41571-021-00539-410.1038/s41571-021-00539-4 ↗
9. 10.1259/0007-1285-26-312-63810.1259/0007-1285-26-312-638 ↗
10. Hyperbaric oxygen and radiobiology of a C3H mouse mammary carcinoma
11. 10.1038/bjc.1961.910.1038/bjc.1961.9 ↗
12. 10.1016/j.ijrobp.2021.03.00110.1016/j.ijrobp.2021.03.001 ↗
13. 10.1016/S1535-6108(04)00115-110.1016/S1535-6108(04)00115-1 ↗
14. 10.1073/pnas.231170712010.1073/pnas.2311707120 ↗
15. 10.1016/j.medj.2021.04.00410.1016/j.medj.2021.04.004 ↗
16. 10.1016/S0167-8140(97)00220-X10.1016/S0167-8140(97)00220-X ↗
17. 10.1002/pbc.2105710.1002/pbc.21057 ↗
18. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
19. 10.1200/JCO.2006.06.273710.1200/JCO.2006.06.2737 ↗
20. 10.1259/0007-1285-51-611-87910.1259/0007-1285-51-611-879 ↗
21. Hyperbaric oxygenation for tumour sensitisation to radiotherapy
22. 10.1007/s10147-017-1213-z10.1007/s10147-017-1213-z ↗
23. 10.1158/1078-0432.CCR-22-166510.1158/1078-0432.CCR-22-1665 ↗
24. 10.1016/j.ijrobp.2015.06.00310.1016/j.ijrobp.2015.06.003 ↗
25. 10.1200/JCO.2010.28.495010.1200/JCO.2010.28.4950 ↗
26. 10.1016/S0167-8140(98)00043-710.1016/S0167-8140(98)00043-7 ↗
27. 10.1016/S0360-3016(01)02678-510.1016/S0360-3016(01)02678-5 ↗
28. 10.1016/j.radonc.2020.03.02510.1016/j.radonc.2020.03.025 ↗
29. 10.1016/0360-3016(94)90158-910.1016/0360-3016(94)90158-9 ↗
30. 10.1016/0167-8140(91)90202-R10.1016/0167-8140(91)90202-R ↗
31. 10.1016/j.ijrobp.2011.09.05010.1016/j.ijrobp.2011.09.050 ↗